SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001354488-15-004008
Filing Date
2015-08-20
Accepted
2015-08-20 09:52:36
Documents
1
Period of Report
2015-08-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT issuerdirect_section16.html 4  
1 PRIMARY DOCUMENT issuerdirect_section16.xml 4 2845
  Complete submission text file 0001354488-15-004008.txt   4417
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Issuer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 747 CLARENDON ROAD PENN VALLEY PA 19072
Business Address
Siegel Barry J (Reporting) CIK: 0001651321 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14494 | Film No.: 151065508